These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 23770226)

  • 1. Mathematical modeling of drug release from nanostructured porous Si: combining carrier erosion and hindered drug diffusion for predicting release kinetics.
    Tzur-Balter A; Young JM; Bonanno-Young LM; Segal E
    Acta Biomater; 2013 Sep; 9(9):8346-53. PubMed ID: 23770226
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Engineering porous silicon nanostructures as tunable carriers for mitoxantrone dihydrochloride.
    Tzur-Balter A; Gilert A; Massad-Ivanir N; Segal E
    Acta Biomater; 2013 Apr; 9(4):6208-17. PubMed ID: 23274152
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Engineering the chemistry and nanostructure of porous silicon Fabry-Pérot films for loading and release of a steroid.
    Anglin EJ; Schwartz MP; Ng VP; Perelman LA; Sailor MJ
    Langmuir; 2004 Dec; 20(25):11264-9. PubMed ID: 15568884
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Can Be a Bimetal Oxide ZnO-MgO Nanoparticles Anticancer Drug Carrier and Deliver? Doxorubicin Adsorption/Release Study.
    Kumar R; Gokulakrishnan N; Kumar R; Krishna VM; Saravanan A; Supriya S; Somanathan T
    J Nanosci Nanotechnol; 2015 Feb; 15(2):1543-53. PubMed ID: 26353689
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular release from patterned nanoporous gold thin films.
    Kurtulus O; Daggumati P; Seker E
    Nanoscale; 2014 Jun; 6(12):7062-71. PubMed ID: 24842586
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Surface chemistry and pore size affect carrier properties of mesoporous silicon microparticles.
    Limnell T; Riikonen J; Salonen J; Kaukonen AM; Laitinen L; Hirvonen J; Lehto VP
    Int J Pharm; 2007 Oct; 343(1-2):141-7. PubMed ID: 17600644
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of Surface Chemistry on the Release of an Antibacterial Drug from Nanostructured Porous Silicon.
    Wang M; Hartman PS; Loni A; Canham LT; Bodiford N; Coffer JL
    Langmuir; 2015 Jun; 31(22):6179-85. PubMed ID: 25970551
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Surface chemistry of porous silicon and implications for drug encapsulation and delivery applications.
    Jarvis KL; Barnes TJ; Prestidge CA
    Adv Colloid Interface Sci; 2012 Jul; 175():25-38. PubMed ID: 22521238
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cell-specific intracellular anticancer drug delivery from mesoporous silica nanoparticles with pH sensitivity.
    Luo Z; Cai K; Hu Y; Zhang B; Xu D
    Adv Healthc Mater; 2012 May; 1(3):321-5. PubMed ID: 23184747
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diffusion dynamics of small molecules from mesoporous silicon films by real-time optical interferometry.
    Mares JW; Weiss SM
    Appl Opt; 2011 Sep; 50(27):5329-37. PubMed ID: 21947054
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Microfluidic assembly of monodisperse multistage pH-responsive polymer/porous silicon composites for precisely controlled multi-drug delivery.
    Liu D; Zhang H; Herranz-Blanco B; Mäkilä E; Lehto VP; Salonen J; Hirvonen J; Santos HA
    Small; 2014 May; 10(10):2029-38. PubMed ID: 24616278
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sustained antibacterial activity from triclosan-loaded nanostructured mesoporous silicon.
    Wang M; Coffer JL; Dorraj K; Hartman PS; Loni A; Canham LT
    Mol Pharm; 2010 Dec; 7(6):2232-9. PubMed ID: 20973523
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Polycaprolactone thin-film drug delivery systems: Empirical and predictive models for device design.
    Schlesinger E; Ciaccio N; Desai TA
    Mater Sci Eng C Mater Biol Appl; 2015 Dec; 57():232-9. PubMed ID: 26354259
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enantioselectively controlled release of chiral drug (metoprolol) using chiral mesoporous silica materials.
    Guo Z; Du Y; Liu X; Ng SC; Chen Y; Yang Y
    Nanotechnology; 2010 Apr; 21(16):165103. PubMed ID: 20351409
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mesoporous silicon in drug delivery applications.
    Salonen J; Kaukonen AM; Hirvonen J; Lehto VP
    J Pharm Sci; 2008 Feb; 97(2):632-53. PubMed ID: 17546667
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Electronically-responsive delivery from a calcified mesoporous silicon structure.
    Batra I; Coffer JL; Canham LT
    Biomed Microdevices; 2006 Jun; 8(2):93-7. PubMed ID: 16688568
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Selective functionalization of the internal and the external surfaces of mesoporous silicon by liquid masking.
    Wu CC; Sailor MJ
    ACS Nano; 2013 Apr; 7(4):3158-67. PubMed ID: 23451853
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recent advances in porous silicon technology for drug delivery.
    Barnes TJ; Jarvis KL; Prestidge CA
    Ther Deliv; 2013 Jul; 4(7):811-23. PubMed ID: 23883125
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Controlling antibiotic release from mesoporous silica nano drug carriers via self-assembled polyelectrolyte coating.
    Tamanna T; Bulitta JB; Yu A
    J Mater Sci Mater Med; 2015 Feb; 26(2):117. PubMed ID: 25665846
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of mesoporous silicon and non-ordered mesoporous silica materials as drug carriers for itraconazole.
    Kinnari P; Mäkilä E; Heikkilä T; Salonen J; Hirvonen J; Santos HA
    Int J Pharm; 2011 Jul; 414(1-2):148-56. PubMed ID: 21601623
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.